ASAQ in a few words
- A drug combination that meets the latest WHO guidelines for malaria treatment in Africa
- An innovative fixed-dose formulation
A simple dosing regimen:
- 1 tablet per day for 3 days for infants, children and adolescents
- 2 tablets once a day for 3 days for adults
Presentations specifically adapted to children
- State-of-the-art galenical formulation
- Optimized dose ratio to avoid over- and under-dosage
|
In the child’s lower hand, the single ASAQ tablet per day is shown in comparison with the upper hand containing 4 tablets needed per day with current treatments. |
- A combination of well-known drugs with well-documented track records
of efficacy and safety
- A commitment to make it available to all patients, right from the start
- <US$1 for adults and <US$0.50 for children in public markets
- Not patented
- Highest standards of quality enforced through the entire manufacturing process
- The concrete result of an innovative partnership between DNDi and
sanofi-aventis
| 
April 2010
